A significant advance in cancer investigation is emerging with the use of nanobodies to restore dysfunctional p53. This crucial tumor inhibitor protein is frequently disabled in several types of tumors, causing https://mirrorbookmarks.com/story21850488/mini-antibodies-reactivate-tumor-suppressor-p53-the-new-hope-for-cancer-therapy